{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:04:25Z","timestamp":1793833465658,"version":"4.6.1"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108012"],"award-info":[{"award-number":["82020108012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371250"],"award-info":[{"award-number":["82371250"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY24H090006"],"award-info":[{"award-number":["LY24H090006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ23H090002"],"award-info":[{"award-number":["LZ23H090002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03098"],"award-info":[{"award-number":["2024C03098"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024SSYS0018"],"award-info":[{"award-number":["2024SSYS0018"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH177"],"award-info":[{"award-number":["ZR2022QH177"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proteinopathies in neurology typically refer to pathological changes in proteins associated with neurological diseases, such as the aggregation of amyloid \u03b2 and Tau in Alzheimer\u2019s disease, \u03b1-synuclein in Parkinson\u2019s disease and multiple system atrophy, and TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal dementia. Interestingly, these proteins are also commonly found in peripheral tissues, raising important questions about their roles in neurological disorders. Multiple studies have shown that peripherally derived pathological proteins not only travel to the brain through various routes, aggravating brain pathology, but also contribute significantly to peripheral dysfunction, highlighting their crucial impact on neurological diseases. Investigating how these peripherally derived proteins influence the progression of neurological disorders could open new horizons for achieving early diagnosis and treatment. This review summarizes the distribution, transportation pathways, and pathogenic mechanisms of several neurodegenerative disease-related pathological proteins in the periphery, proposing that targeting these peripheral pathological proteins could be a promising strategy for preventing and managing neurological diseases.<\/jats:p>","DOI":"10.1186\/s40035-024-00461-6","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T01:58:05Z","timestamp":1736992685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Peripheral proteinopathy in neurodegenerative diseases"],"prefix":"10.1186","volume":"14","author":[{"given":"Bin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-8317","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"6","key":"461_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","volume":"25","author":"R Coukos","year":"2024","unstructured":"Coukos R, Krainc D. Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat Rev Neurosci. 2024;25(6):393\u2013413.","journal-title":"Nat Rev Neurosci"},{"issue":"7994","key":"461_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41586-023-06801-2","volume":"625","author":"S Tetter","year":"2024","unstructured":"Tetter S, Arseni D, Murzin AG, Buhidma Y, Peak-Chew SY, Garringer HJ, et al. TAF15 amyloid filaments in frontotemporal lobar degeneration. Nature. 2024;625(7994):345\u201351.","journal-title":"Nature"},{"issue":"1","key":"461_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey J, Venkatesh S, Hasan R, Herb JT, de Paiva LK, Kucukali F, et al. Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci. 2023;26(1):150\u201362.","journal-title":"Nat Neurosci"},{"issue":"20","key":"461_CR4","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1016\/j.cell.2023.08.038","volume":"186","author":"V Dileep","year":"2023","unstructured":"Dileep V, Boix CA, Mathys H, Marco A, Welch GM, Meharena HS, et al. Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration. Cell. 2023;186(20):4404\u201321.","journal-title":"Cell"},{"issue":"4","key":"461_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn AD, Grinberg LT. Is Alzheimer disease a disease? Nat Rev Neurol. 2024;20(4):245\u201351.","journal-title":"Nat Rev Neurol"},{"key":"461_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102276","volume":"96","author":"S Bashir","year":"2024","unstructured":"Bashir S, Aiman A, Shahid M, Chaudhary AA, Sami N, Basir SF, et al. Amyloid-induced neurodegeneration: a comprehensive review through aggregomics perception of proteins in health and pathology. Ageing Res Rev. 2024;96: 102276.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"461_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","volume":"30","author":"S Temple","year":"2023","unstructured":"Temple S. Advancing cell therapy for neurodegenerative diseases. Cell Stem Cell. 2023;30(5):512\u201329.","journal-title":"Cell Stem Cell"},{"key":"461_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148688","volume":"1825","author":"A Esmaeili","year":"2024","unstructured":"Esmaeili A, Eteghadi A, Landi FS, Yavari SF, Taghipour N. Recent approaches in regenerative medicine in the fight against neurodegenerative disease. Brain Res. 2024;1825: 148688.","journal-title":"Brain Res"},{"issue":"10","key":"461_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"3","author":"SF Lau","year":"2023","unstructured":"Lau SF, Wu W, Wong HY, Ouyang L, Qiao Y, Xu J, et al. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat Aging. 2023;3(10):1219\u201336.","journal-title":"Nat Aging"},{"issue":"4","key":"461_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1073858420943180","volume":"27","author":"H Zheng","year":"2021","unstructured":"Zheng H, Shi C, Luo H, Fan L, Yang Z, Hu X, et al. Alpha-synuclein in parkinson\u2019s disease: does a prion-like mechanism of propagation from periphery to the brain play a role? Neuroscientist. 2021;27(4):367\u201387.","journal-title":"Neuroscientist"},{"key":"461_CR11","doi-asserted-by":"crossref","unstructured":"Elia A, Parodi-Rullan R, Vazquez-Torres R, Carey A, Javadov S, Fossati S. Amyloid beta induces cardiac dysfunction and neuro-signaling impairment in the heart of an Alzheimer\u2019s disease model. bioRxiv [Preprint]. 2023:2023.07.11.548558. doi: 10.1101\/2023.07.11.548558.","DOI":"10.1101\/2023.07.11.548558"},{"issue":"9","key":"461_CR12","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100718R","volume":"35","author":"R Balczon","year":"2021","unstructured":"Balczon R, Lin MT, Lee JY, Abbasi A, Renema P, Voth SB, et al. Pneumonia initiates a tauopathy. FASEB J. 2021;35(9): e21807.","journal-title":"FASEB J"},{"key":"461_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101451","volume":"71","author":"R Ullah","year":"2021","unstructured":"Ullah R, Park TJ, Huang X, Kim MO. Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: insights and therapeutic approaches from periphery. Ageing Res Rev. 2021;71: 101451.","journal-title":"Ageing Res Rev"},{"key":"461_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105273","volume":"151","author":"A Marquez","year":"2021","unstructured":"Marquez A, Guernsey LS, Frizzi KE, Cundiff M, Constantino I, Muttalib N, et al. Tau associated peripheral and central neurodegeneration: identification of an early imaging marker for tauopathy. Neurobiol Dis. 2021;151: 105273.","journal-title":"Neurobiol Dis"},{"issue":"15","key":"461_CR15","doi-asserted-by":"publisher","first-page":"e1529","DOI":"10.1212\/WNL.0000000000206772","volume":"100","author":"C Gibbons","year":"2023","unstructured":"Gibbons C, Wang N, Rajan S, Kern D, Palma JA, Kaufmann H, et al. Cutaneous alpha-synuclein signatures in patients with multiple system atrophy and parkinson disease. Neurology. 2023;100(15):e1529\u201339.","journal-title":"Neurology"},{"issue":"3","key":"461_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120(3):885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"461_CR17","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","volume":"4","author":"CL Masters","year":"1985","unstructured":"Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K. Neuronal origin of a cerebral amyloid neurofibrillary tangles of Alzheimer\u2019s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 1985;4(11):2757\u201363.","journal-title":"EMBO J"},{"key":"461_CR18","doi-asserted-by":"crossref","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985;82(12):4245-9.","DOI":"10.1073\/pnas.82.12.4245"},{"issue":"12","key":"461_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2174\/1567205018666210119151952","volume":"17","author":"AM Floden","year":"2020","unstructured":"Floden AM, Sohrabi M, Nookala S, Cao JJ, Combs CK. Salivary abeta secretion and altered oral microbiome in mouse models of AD. Curr Alzheimer Res. 2020;17(12):1133\u201344.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"461_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","volume":"5","author":"AE Roher","year":"2009","unstructured":"Roher AE, Esh CL, Kokjohn TA, Castano EM, Van Vickle GD, Kalback WM, et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease. Alzheimers Dement. 2009;5(1):18\u201329.","journal-title":"Alzheimers Dement"},{"key":"461_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152565","author":"P Yan","year":"2022","unstructured":"Yan P, Kim KW, Xiao Q, Ma X, Czerniewski LR, Liu H, et al. Peripheral monocyte-derived cells counter amyloid plaque pathogenesis in a mouse model of Alzheimer\u2019s disease. J Clin Invest. 2022;132(11): e152565.","journal-title":"J Clin Invest"},{"issue":"10","key":"461_CR22","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1002\/alz.13388","volume":"19","author":"Q Tian","year":"2023","unstructured":"Tian Q, Bilgel M, Walker KA, Moghekar AR, Fishbein KW, Spencer RG, et al. Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer\u2019s disease and neurodegeneration. Alzheimers Dement. 2023;19(10):4436\u201345.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"461_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/brainsci11091245","volume":"11","author":"A Torcinaro","year":"2021","unstructured":"Torcinaro A, Ricci V, Strimpakos G, De Santa F, Middei S. Peripheral nerve impairment in a mouse model of Alzheimer\u2019s disease. Brain Sci. 2021;11(9):1245.","journal-title":"Brain Sci"},{"issue":"5","key":"461_CR24","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.18632\/aging.202662","volume":"13","author":"T Wu","year":"2021","unstructured":"Wu T, Chen L, Zhou L, Xu J, Guo K. Platelets transport beta-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer\u2019s disease in mouse models. Aging (Albany NY). 2021;13(5):7644\u201359.","journal-title":"Aging (Albany NY)"},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"120855","DOI":"10.1016\/j.lfs.2022.120855","volume":"306","author":"SK Beura","year":"2022","unstructured":"Beura SK, Dhapola R, Panigrahi AR, Yadav P, Reddy DH, Singh SK. Redefining oxidative stress in Alzheimer\u2019s disease: targeting platelet reactive oxygen species for novel therapeutic options. Life Sci. 2022;306:120855.","journal-title":"Life Sci"},{"issue":"4","key":"461_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/jpm10040232","volume":"10","author":"A Bhattacharya","year":"2020","unstructured":"Bhattacharya A, Izzo A, Mollo N, Napolitano F, Limone A, Margheri F, et al. Inhibition of 37\/67kDa Laminin-1 receptor restores APP maturation and reduces amyloid-beta in human skin fibroblasts from familial Alzheimer\u2019s disease. J Pers Med. 2020;10(4):232.","journal-title":"J Pers Med."},{"issue":"24","key":"461_CR27","doi-asserted-by":"publisher","first-page":"9675","DOI":"10.3390\/ijms21249675","volume":"21","author":"R Herrero-Labrador","year":"2020","unstructured":"Herrero-Labrador R, Trueba-Saiz A, Martinez-Rachadell L, Fernandez de Sevilla ME, Zegarra-Valdivia JA, Pignatelli J, et al. Circulating insulin-like growth factor I is involved in the effect of high fat diet on peripheral amyloid beta clearance. Int J Mol Sci. 2020;21(24):9675.","journal-title":"Int J Mol Sci"},{"key":"461_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-981-13-8871-2_11","volume":"1165","author":"BC Liu","year":"2019","unstructured":"Liu BC, Tang TT, Lv LL. How tubular epithelial cell injury contributes to renal fibrosis. Adv Exp Med Biol. 2019;1165:233\u201352.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"461_CR29","doi-asserted-by":"publisher","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin J, Xu Z, Zhang L, Zhang C, Zhao X, Mao Y, et al. Gut-derived beta-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes. 2023;15(1):2167172.","journal-title":"Gut Microbes"},{"issue":"1","key":"461_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-023-03003-5","volume":"21","author":"M Shi","year":"2024","unstructured":"Shi M, Chu F, Zhu F, Zhu J. Peripheral blood amyloid-\u03b2 involved in the pathogenesis of Alzheimer\u2019s disease via impacting on peripheral innate immune cells. J Neuroinflammation. 2024;21(1):5.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"461_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13195-023-01296-5","volume":"15","author":"S Bun","year":"2023","unstructured":"Bun S, Ito D, Tezuka T, Kubota M, Ueda R, Takahata K, et al. Performance of plasma A\u03b242\/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status. Alzheimers Res Ther. 2023;15(1):149.","journal-title":"Alzheimers Res Ther"},{"issue":"20","key":"461_CR32","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1039\/D0SC02060E","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Zhu B, Yin W, Han Z, Zheng C, Wang P, et al. Differentiating A\u03b240 and A\u03b242 in amyloid plaques with a small molecule fluorescence probe. Chem Sci. 2020;11(20):5238\u201345.","journal-title":"Chem Sci"},{"issue":"10","key":"461_CR33","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol. 2017;13(10):612\u201323.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"461_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","volume":"33","author":"RJDR GuerreiroGustafson","year":"2012","unstructured":"Guerreiro RJ, Gustafson DR, Hardy J. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol Aging. 2012;33(3):437\u201356.","journal-title":"PSENs and APOE Neurobiol Aging"},{"issue":"1","key":"461_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-024-00434-9","volume":"13","author":"N Liu","year":"2024","unstructured":"Liu N, Haziyihan A, Zhao W, Chen Y, Chao H. Trajectory of brain-derived amyloid beta in Alzheimer\u2019s disease: where is it coming from and where is it going? Transl Neurodegener. 2024;13(1):42.","journal-title":"Transl Neurodegener"},{"issue":"6239","key":"461_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/341226a0","volume":"341","author":"CL Joachim","year":"1989","unstructured":"Joachim CL, Mori H, Selkoe DJ. Amyloid beta-protein deposition in tissues other than brain in Alzheimer\u2019s disease. Nature. 1989;341(6239):226\u201330.","journal-title":"Nature"},{"issue":"1\u20134","key":"461_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000335154","volume":"10","author":"Y Koronyo","year":"2012","unstructured":"Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M. Alzheimer\u2019s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment. Neurodegener Dis. 2012;10(1\u20134):285\u201393.","journal-title":"Neurodegener Dis"},{"issue":"22","key":"461_CR38","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","volume":"68","author":"L Troncone","year":"2016","unstructured":"Troncone L, Luciani M, Coggins M, Wilker EH, Ho CY, Codispoti KE, et al. Abeta Amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: mind the heart. J Am Coll Cardiol. 2016;68(22):2395\u2013407.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"461_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108660","volume":"34","author":"M Romani","year":"2021","unstructured":"Romani M, Sorrentino V, Oh CM, Li H, de Lima TI, Zhang H, et al. NAD(+) boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle. Cell Rep. 2021;34(3): 108660.","journal-title":"Cell Rep"},{"issue":"4","key":"461_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","volume":"54","author":"JY Hur","year":"2022","unstructured":"Hur JY. Gamma-Secretase in Alzheimer\u2019s disease. Exp Mol Med. 2022;54(4):433\u201346.","journal-title":"Exp Mol Med"},{"issue":"6700","key":"461_CR41","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.adn5820","volume":"384","author":"X Guo","year":"2024","unstructured":"Guo X, Li H, Yan C, Lei J, Zhou R, Shi Y. Molecular mechanism of substrate recognition and cleavage by human gamma-secretase. Science. 2024;384(6700):1091\u20135.","journal-title":"Science"},{"issue":"7","key":"461_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13430","volume":"23","author":"HA Taylor","year":"2022","unstructured":"Taylor HA, Przemylska L, Clavane EM, Meakin PJ. BACE1: More than just a \u03b2-secretase. Obes Rev. 2022;23(7): e13430.","journal-title":"Obes Rev"},{"issue":"6","key":"461_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s44318-024-00057-w","volume":"43","author":"B De Strooper","year":"2024","unstructured":"De Strooper B, Karran E. New precision medicine avenues to the prevention of Alzheimer\u2019s disease from insights into the structure and function of gamma-secretases. EMBO J. 2024;43(6):887\u2013903.","journal-title":"EMBO J"},{"issue":"12","key":"461_CR44","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/j.bbamem.2013.04.016","volume":"1828","author":"N Jurisch-Yaksi","year":"2013","unstructured":"Jurisch-Yaksi N, Sannerud R, Annaert W. A fast growing spectrum of biological functions of gamma-secretase in development and disease. Biochim Biophys Acta. 2013;1828(12):2815\u201327.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"461_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s42003-020-0865-9","volume":"3","author":"A Pastore","year":"2020","unstructured":"Pastore A, Raimondi F, Rajendran Temussi LPA. Why does the A\u03b2 peptide of Alzheimer share structural similarity with antimicrobial peptides? Commun Biol. 2020;3(1):135.","journal-title":"Commun Biol"},{"issue":"340","key":"461_CR46","doi-asserted-by":"publisher","first-page":"340ra72","DOI":"10.1126\/scitranslmed.aaf1059","volume":"8","author":"DK Kumar","year":"2016","unstructured":"Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci Transl Med. 2016;8(340):340ra72.","journal-title":"Sci Transl Med."},{"issue":"6","key":"461_CR47","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3390\/microorganisms9061301","volume":"9","author":"G Tetz","year":"2021","unstructured":"Tetz G, Tetz V. Bacterial extracellular DNA promotes \u03b2-amyloid aggregation. Microorganisms. 2021;9(6):1301.","journal-title":"Microorganisms."},{"issue":"2","key":"461_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer\u2019s disease animal model. Gut. 2020;69(2):283\u201394.","journal-title":"Gut"},{"issue":"1","key":"461_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5056\/jnm18087","volume":"25","author":"K Kowalski","year":"2019","unstructured":"Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer\u2019s disease. J Neurogastroenterol Motil. 2019;25(1):48\u201360.","journal-title":"J Neurogastroenterol Motil"},{"issue":"17","key":"461_CR50","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111515","volume":"42","author":"J Xie","year":"2023","unstructured":"Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, et al. Gut microbiota regulates blood-cerebrospinal fluid barrier function and A\u03b2 pathology. Embo j. 2023;42(17): e111515.","journal-title":"Embo j"},{"issue":"11","key":"461_CR51","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71(11):2233\u201352.","journal-title":"Gut"},{"issue":"8","key":"461_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300070","volume":"7","author":"Y Tang","year":"2023","unstructured":"Tang Y, Zhang D, Robinson S, Zheng J. Inhibition of pancreatic cancer cells by different amyloid proteins reveals an inverse relationship between neurodegenerative diseases and cancer. Adv Biol (Weinh). 2023;7(8): e2300070.","journal-title":"Adv Biol (Weinh)"},{"issue":"1","key":"461_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/B:AGEN.0000037335.17717.bf","volume":"7","author":"D Paris","year":"2004","unstructured":"Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, et al. Inhibition of angiogenesis by Abeta peptides. Angiogenesis. 2004;7(1):75\u201385.","journal-title":"Angiogenesis"},{"issue":"1","key":"461_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12979-023-00366-4","volume":"20","author":"C Li","year":"2023","unstructured":"Li C, Liu K, Zhu J, Zhu F. The effects of high plasma levels of A\u03b2(1\u201342) on mononuclear macrophage in mouse models of Alzheimer\u2019s disease. Immun Ageing. 2023;20(1):39.","journal-title":"Immun Ageing"},{"issue":"1","key":"461_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","volume":"18","author":"X Taylor","year":"2023","unstructured":"Taylor X, Clark IM, Fitzgerald GJ, Oluoch H, Hole JT, DeMattos RB, et al. Amyloid-\u03b2 (A\u03b2) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer\u2019s disease mice. Mol Neurodegener. 2023;18(1):59.","journal-title":"Mol Neurodegener"},{"key":"461_CR56","first-page":"34","volume":"25","author":"K Poinsatte","year":"2019","unstructured":"Poinsatte K, Smith EE, Torres VO, Ortega SB, Huebinger RM, Cullum CM, et al. T and B cell subsets differentially correlate with amyloid deposition and neurocognitive function in patients with amnestic mild cognitive impairment after one year of physical activity. Exerc Immunol Rev. 2019;25:34\u201349.","journal-title":"Exerc Immunol Rev"},{"issue":"1","key":"461_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13024-023-00692-7","volume":"18","author":"P Yeapuri","year":"2023","unstructured":"Yeapuri P, Machhi J, Lu Y, Abdelmoaty MM, Kadry R, Patel M, et al. Amyloid-\u03b2 specific regulatory T cells attenuate Alzheimer\u2019s disease pathobiology in APP\/PS1 mice. Mol Neurodegener. 2023;18(1):97.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"461_CR58","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A. 1975;72(5):1858\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"461_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):22\u201335.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"461_CR60","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1073\/pnas.89.5.1983","volume":"89","author":"M Goedert","year":"1992","unstructured":"Goedert M, Spillantini MG, Crowther RA. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc Natl Acad Sci U S A. 1992;89(5):1983\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"461_CR61","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cne.903580209","volume":"358","author":"LJ Boyne","year":"1995","unstructured":"Boyne LJ, Tessler A, Murray M, Fischer I. Distribution of Big tau in the central nervous system of the adult and developing rat. J Comp Neurol. 1995;358(2):279\u201393.","journal-title":"J Comp Neurol"},{"issue":"Pt 3","key":"461_CR62","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1242\/jcs.105.3.729","volume":"105","author":"IS Georgieff","year":"1993","unstructured":"Georgieff IS, Liem RK, Couchie D, Mavilia C, Nunez J, Shelanski ML. Expression of high molecular weight tau in the central and peripheral nervous systems. J Cell Sci. 1993;105(Pt 3):729\u201337.","journal-title":"J Cell Sci"},{"issue":"8","key":"461_CR63","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/brain\/awac281","volume":"145","author":"BN Dugger","year":"2022","unstructured":"Dugger BN, Harvey D, Beach TG, Adler CH. Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars? Brain. 2022;145(8):2629\u201331.","journal-title":"Brain"},{"key":"461_CR64","doi-asserted-by":"publisher","first-page":"1166848","DOI":"10.3389\/fnins.2023.1166848","volume":"17","author":"G Chapelet","year":"2023","unstructured":"Chapelet G, B\u00e9guin N, Castellano B, Grit I, de Coppet P, Oullier T, et al. Tau expression and phosphorylation in enteroendocrine cells. Front Neurosci. 2023;17:1166848.","journal-title":"Front Neurosci"},{"key":"461_CR65","doi-asserted-by":"crossref","unstructured":"Solorzano A, Brady M, Bhatt N, Johnson A, Burgess B, Leyva H, et al. Central and peripheral tau retention modulated by an anti-tau antibody. bioRxiv [Preprint]. 2023:2023.08.17.553682. doi: 10.1101\/2023.08.17.553682.","DOI":"10.1101\/2023.08.17.553682"},{"issue":"1","key":"461_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101482","volume":"298","author":"CS Choi","year":"2022","unstructured":"Choi CS, Gwin M, Voth S, Kolb C, Zhou C, Nelson AR, et al. Cytotoxic tau released from lung microvascular endothelial cells upon infection with Pseudomonas aeruginosa promotes neuronal tauopathy. J Biol Chem. 2022;298(1): 101482.","journal-title":"J Biol Chem"},{"issue":"2","key":"461_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/JAD-150859","volume":"51","author":"BN Dugger","year":"2016","unstructured":"Dugger BN, Whiteside CM, Maarouf CL, Walker DG, Beach TG, Sue LI, et al. The presence of select Tau species in human peripheral tissues and their relation to Alzheimer\u2019s disease. J Alzheimers Dis. 2016;51(2):345\u201356.","journal-title":"J Alzheimers Dis"},{"key":"461_CR68","doi-asserted-by":"crossref","unstructured":"Alava B, Hery G, Sidhom S, Gutierrez-Monreal M, Prokop S, Esser KA, et al. Targeted brain-specific tauopathy compromises peripheral skeletal muscle integrity and function. Aging Brain. 2024;5:100110.","DOI":"10.1016\/j.nbas.2024.100110"},{"issue":"2","key":"461_CR69","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-022-02525-1","volume":"145","author":"FJ Hart de Ruyter","year":"2023","unstructured":"Hart de Ruyter FJ, Morrema THJ, den Haan J, Netherlands Brain B, Twisk JWR, de Boer JF, et al. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer\u2019s disease and primary tauopathies. Acta Neuropathol. 2023;145(2):197\u2013218.","journal-title":"Acta Neuropathol"},{"key":"461_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2023.137330","volume":"810","author":"Y Hamsafar","year":"2023","unstructured":"Hamsafar Y, Chen Q, Borowsky AD, Beach TG, Serrano GE, Sue LI, et al. Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease. Neurosci Lett. 2023;810: 137330.","journal-title":"Neurosci Lett"},{"issue":"2","key":"461_CR71","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-161093","volume":"56","author":"AH Betrie","year":"2017","unstructured":"Betrie AH, Ayton S, Bush AI, Angus JA, Lei PCE, Wright. Evidence of a cardiovascular function for microtubule-associated protein Tau. J Alzheimers Dis. 2017;56(2):849\u201360.","journal-title":"J Alzheimers Dis"},{"key":"461_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.595532","volume":"11","author":"C Alquezar","year":"2021","unstructured":"Alquezar C, Arya S, Kao AW. Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation. Front Neurol. 2021;11: 595532.","journal-title":"Front Neurol"},{"issue":"2","key":"461_CR73","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/JAD-150859","volume":"51","author":"BN Dugger","year":"2016","unstructured":"Dugger BN, Whiteside CM, Maarouf CL, Walker DG, Beach TG, Sue LI, et al. The presence of select tau species in human peripheral tissues and their relation to Alzheimer\u2019s disease. J Alzheimers Dis. 2016;51(2):345\u201356.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"461_CR74","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 2024;81(3):255\u201363.","journal-title":"JAMA Neurol"},{"issue":"1","key":"461_CR75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"461_CR76","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.tins.2020.04.007","volume":"43","author":"I Fischer","year":"2020","unstructured":"Fischer I, Baas PW. Resurrecting the mysteries of big Tau. Trends Neurosci. 2020;43(7):493\u2013504.","journal-title":"Trends Neurosci"},{"key":"461_CR77","volume":"18","author":"C DeC","year":"2022","unstructured":"DeC C, Revelli JP, Richman R, Yalamanchili HK, Kang MG, Han A, et al. The potentially protective role of an understudied tau isoform in Alzheimer\u2019s disease. Alzheimers Dement. 2022;18: 059890.","journal-title":"Alzheimer\u2019s & Dementia."},{"issue":"17","key":"461_CR78","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/eurheartj\/ehad205","volume":"44","author":"M Luciani","year":"2023","unstructured":"Luciani M, Montalbano M, Troncone L, Bacchin C, Uchida K, Daniele G, et al. Big tau aggregation disrupts microtubule tyrosination and causes myocardial diastolic dysfunction: from discovery to therapy. Eur Heart J. 2023;44(17):1560\u201370.","journal-title":"Eur Heart J"},{"issue":"7","key":"461_CR79","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41569-023-00890-2","volume":"20","author":"GB Lim","year":"2023","unstructured":"Lim GB. Aggregation of big tau disrupts microtubules and causes diastolic dysfunction. Nat Rev Cardiol. 2023;20(7):441.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"461_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298816","volume":"19","author":"P Renema","year":"2024","unstructured":"Renema P, Pittet JF, Brandon AP, Leal SM Jr, Gu S, Promer G, et al. Tau and A\u03b242 in lavage fluid of pneumonia patients are associated with end-organ dysfunction: a prospective exploratory study. PLoS One. 2024;19(2): e0298816.","journal-title":"PLoS ONE"},{"issue":"7","key":"461_CR81","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300620RR","volume":"37","author":"R Balczon","year":"2023","unstructured":"Balczon R, Choi CS, deWeever A, Zhou C, Gwin MS, Kolb C, et al. Infection promotes Ser-214 phosphorylation important for generation of cytotoxic tau variants. FASEB J. 2023;37(7): e23042.","journal-title":"Faseb j"},{"key":"461_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbas.2024.100110","volume":"5","author":"B Alava","year":"2024","unstructured":"Alava B, Hery G, Sidhom S, Gutierrez-Monreal M, Prokop S, Esser KA, et al. Targeted brain-specific tauopathy compromises peripheral skeletal muscle integrity and function. Aging Brain. 2024;5: 100110.","journal-title":"Aging Brain"},{"key":"461_CR83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F. Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease. Front Neurosci. 2018;12:80.","journal-title":"Front Neurosci"},{"issue":"3","key":"461_CR84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, et al. \u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol. 2021;142(3):495\u2013511.","journal-title":"Acta Neuropathol"},{"key":"461_CR85","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F. Mechanisms of alpha-Synuclein induced synaptopathy in Parkinson\u2019s disease. Front Neurosci. 2018;12:80.","journal-title":"Front Neurosci"},{"key":"461_CR86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0070-2153(04)60002-0","volume":"60","author":"EH Norris","year":"2004","unstructured":"Norris EH, Giasson BI, Lee VM. Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr Top Dev Biol. 2004;60:17\u201354.","journal-title":"Curr Top Dev Biol"},{"issue":"9","key":"461_CR87","doi-asserted-by":"publisher","first-page":"e1267","DOI":"10.1212\/WNL.0000000000010404","volume":"95","author":"LM Chahine","year":"2020","unstructured":"Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, et al. In vivo distribution of \u03b1-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology. 2020;95(9):e1267\u201384.","journal-title":"Neurology"},{"issue":"3","key":"461_CR88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","volume":"137","author":"L Veys","year":"2019","unstructured":"Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L, et al. Retinal alpha-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathol. 2019;137(3):379\u201395.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"461_CR89","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.4081\/ejh.2021.3310","volume":"65","author":"A Casini","year":"2021","unstructured":"Casini A, Mancinelli R, Mammola CL, Pannarale L, Chirletti P, Onori P, et al. Distribution of \u03b1-synuclein in normal human jejunum and its relations with the chemosensory and neuroendocrine system. Eur J Histochem. 2021;65(4):3310.","journal-title":"Eur J Histochem"},{"issue":"8","key":"461_CR90","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1007\/s12035-023-03345-4","volume":"60","author":"W Jiang","year":"2023","unstructured":"Jiang W, Cheng Y, Wang Y, Wu J, Rong Z, Sun L, et al. Involvement of abnormal p-\u03b1-syn accumulation and TLR2-mediated inflammation of schwann cells in enteric autonomic nerve dysfunction of parkinson\u2019s disease: an animal model study. Mol Neurobiol. 2023;60(8):4738\u201352.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"461_CR91","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","volume":"10","author":"LY Ma","year":"2019","unstructured":"Ma LY, Liu GL, Wang DX, Zhang MM, Kou WY, Feng T. Alpha-synuclein in peripheral tissues in parkinson\u2019s disease. ACS Chem Neurosci. 2019;10(2):812\u201323.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"461_CR92","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-021-01136-3","volume":"9","author":"JF Reyes","year":"2021","unstructured":"Reyes JF, Ekmark-L\u00e9wen S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson\u2019s disease. Acta Neuropathol Commun. 2021;9(1):46.","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"461_CR93","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, Banducci K, Cole T, Diep L, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008;5(2):55\u20139.","journal-title":"Neurodegener Dis"},{"issue":"7362","key":"461_CR94","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels T, Choi JG, Selkoe DJ. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477(7362):107\u201310.","journal-title":"Nature"},{"issue":"2","key":"461_CR95","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12013-007-0014-9","volume":"47","author":"K Beyer","year":"2007","unstructured":"Beyer K. Mechanistic aspects of Parkinson\u2019s disease: alpha-synuclein and the biomembrane. Cell Biochem Biophys. 2007;47(2):285\u201399.","journal-title":"Cell Biochem Biophys"},{"key":"461_CR96","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neurobiolaging.2022.02.010","volume":"113","author":"JT Oliveira","year":"2022","unstructured":"Oliveira JT, Dakic V, Vit\u00f3ria G, Pedrosa C, Mendes M, Arag\u00e3o L, et al. Oligomeric \u03b1-Synuclein induces skin degeneration in reconstructed human epidermis. Neurobiol Aging. 2022;113:108\u201317.","journal-title":"Neurobiol Aging"},{"key":"461_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104076","volume":"80","author":"Y Han","year":"2022","unstructured":"Han Y, Wu D, Wang Y, Xie J, Zhang Z. Skin alpha-synuclein deposit patterns: a predictor of Parkinson\u2019s disease subtypes. EBioMedicine. 2022;80: 104076.","journal-title":"EBioMedicine"},{"issue":"9","key":"461_CR98","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/vaccines10091432","volume":"10","author":"S Schmidhuber","year":"2022","unstructured":"Schmidhuber S, Scheiblhofer S, Weiss R, Cserepes M, T\u00f3v\u00e1ri J, Gadermaier G, et al. A Novel C-type lectin receptor-targeted \u03b1-synuclein-based parkinson vaccine induces potent immune responses and therapeutic efficacy in mice. Vaccines (Basel). 2022;10(9):1432.","journal-title":"Vaccines (Basel)."},{"issue":"1","key":"461_CR99","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E. The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14(1):38\u201348.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"461_CR100","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015;14(6):625\u201339.","journal-title":"Lancet Neurol"},{"issue":"1","key":"461_CR101","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mds.29620","volume":"39","author":"Y Yang","year":"2024","unstructured":"Yang Y, Stewart T, Zhang C, Wang P, Xu Z, Jin J, et al. Erythrocytic \u03b1-synuclein and the gut microbiome: kindling of the gut-brain axis in Parkinson\u2019s disease. Mov Disord. 2024;39(1):40\u201352.","journal-title":"Mov Disord"},{"issue":"3","key":"461_CR102","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, et al. Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23(3):327\u201336.","journal-title":"Nat Neurosci"},{"issue":"4","key":"461_CR103","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","volume":"22","author":"P Tziortzouda","year":"2021","unstructured":"Tziortzouda P, VanDen Bosch L, Hirth F. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat Rev Neurosci. 2021;22(4):197\u2013208.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"461_CR104","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","volume":"92","author":"EMJ de Boer","year":"2020","unstructured":"de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2020;92(1):86\u201395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"461_CR105","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22(8):869\u201378.","journal-title":"Nat Med"},{"issue":"1","key":"461_CR106","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40478-019-0776-5","volume":"7","author":"K Nishino","year":"2019","unstructured":"Nishino K, Watanabe S, Shijie J, Murata Y, Oiwa K, Komine O, et al. Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway. Acta Neuropathol Commun. 2019;7(1):118.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"461_CR107","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-024-00419-8","volume":"13","author":"JI Lopez-Carbonero","year":"2024","unstructured":"Lopez-Carbonero JI, Garcia-Toledo I, Fernandez-Hernandez L, Bascunana P, Gil-Moreno MJ, Matias-Guiu JA, et al. In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use. Transl Neurodegener. 2024;13(1):29.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"461_CR108","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2990.2010.01108.x","volume":"37","author":"C D\u2019Agostino","year":"2011","unstructured":"D\u2019Agostino C, Nogalska A, Engel WK, Askanas V. In sporadic inclusion body myositis muscle fibres TDP-43-positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments. Neuropathol Appl Neurobiol. 2011;37(3):315\u201320.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"10","key":"461_CR109","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","volume":"79","author":"CC Weihl","year":"2008","unstructured":"Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008;79(10):1186\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"461_CR110","doi-asserted-by":"publisher","first-page":"e13261","DOI":"10.1111\/bpa.13261","volume":"34","author":"QJ Zhang","year":"2024","unstructured":"Zhang QJ, Lin J, Wang YL, Chen L, Ding Y, Zheng FZ, et al. Detection of pTDP-43 via routine muscle biopsy: a promising diagnostic biomarker for amyotrophic lateral sclerosis. Brain Pathol. 2024;34(6):e13261.","journal-title":"Brain Pathol"},{"issue":"1","key":"461_CR111","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-019-0824-1","volume":"7","author":"F Mori","year":"2019","unstructured":"Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H, et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun. 2019;7(1):165.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"461_CR112","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-018-0528-y","volume":"6","author":"MD Cykowski","year":"2018","unstructured":"Cykowski MD, Powell SZ, Appel JW, Arumanayagam AS, Rivera AL, Appel SH. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2018;6(1):28.","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"461_CR113","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2022.1113","volume":"79","author":"T Kurashige","year":"2022","unstructured":"Kurashige T, Morino H, Murao T, Izumi Y, Sugiura T, Kuraoka K, et al. TDP-43 accumulation within intramuscular nerve bundles of patients with amyotrophic lateral sclerosis. JAMA Neurol. 2022;79(7):693\u2013701.","journal-title":"JAMA Neurol"},{"issue":"3","key":"461_CR114","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrn2786","volume":"11","author":"B Frost","year":"2010","unstructured":"Frost B, Diamond MI. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci. 2010;11(3):155\u20139.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"461_CR115","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/nan.12592","volume":"46","author":"Z Jaunmuktane","year":"2020","unstructured":"Jaunmuktane Z, Brandner S. Invited review: the role of prion-like mechanisms in neurodegenerative diseases. Neuropathol Appl Neurobiol. 2020;46(6):522\u201345.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"461_CR116","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","volume":"47","author":"SB Prusiner","year":"2013","unstructured":"Prusiner SB. Biology and genetics of prions causing neurodegeneration. Annu Rev Genet. 2013;47:601\u201323.","journal-title":"Annu Rev Genet"},{"issue":"10","key":"461_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009004","volume":"16","author":"R Gomez-Gutierrez","year":"2020","unstructured":"Gomez-Gutierrez R, Morales R. The prion-like phenomenon in Alzheimer\u2019s disease: evidence of pathology transmission in humans. PLoS Pathog. 2020;16(10): e1009004.","journal-title":"PLoS Pathog"},{"issue":"7465","key":"461_CR118","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. 2013;501(7465):45\u201351.","journal-title":"Nature"},{"issue":"4","key":"461_CR119","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DMDewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714.","journal-title":"Cell"},{"issue":"19","key":"461_CR120","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1113\/JP279919","volume":"598","author":"Y Sun","year":"2020","unstructured":"Sun Y, Sommerville NR, Liu JYH, Ngan MP, Poon D, Ponomarev ED, et al. Intra-gastrointestinal amyloid-\u03b21-42 oligomers perturb enteric function and induce Alzheimer\u2019s disease pathology. J Physiol. 2020;598(19):4209\u201323.","journal-title":"J Physiol"},{"issue":"1","key":"461_CR121","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41422-019-0241-9","volume":"30","author":"EH Ahn","year":"2020","unstructured":"Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B, et al. Initiation of Parkinson\u2019s disease from gut to brain by delta-secretase. Cell Res. 2020;30(1):70\u201387.","journal-title":"Cell Res"},{"issue":"4","key":"461_CR122","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models parkinson\u2019s disease. Neuron. 2019;103(4):627\u201341.","journal-title":"Neuron"},{"issue":"1","key":"461_CR123","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12974-021-02086-2","volume":"18","author":"PH Lai","year":"2021","unstructured":"Lai PH, Wang TH, Zhang NY, Wu KC, Yao CJ, Lin CJ. Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis. J Neuroinflammation. 2021;18(1):35.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"461_CR124","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40478-020-00983-w","volume":"8","author":"L Sheng","year":"2020","unstructured":"Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P, et al. Erythrocytic alpha-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson\u2019s disease pathogenesis. Acta Neuropathol Commun. 2020;8(1):102.","journal-title":"Acta Neuropathol Commun"},{"issue":"19","key":"461_CR125","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1113\/JP279919","volume":"598","author":"Y Sun","year":"2020","unstructured":"Sun Y, Sommerville NR, Liu JYH, Ngan MP, Poon D, Ponomarev ED, et al. Intra-gastrointestinal amyloid-beta1-42 oligomers perturb enteric function and induce Alzheimer\u2019s disease pathology. J Physiol. 2020;598(19):4209\u201323.","journal-title":"J Physiol"},{"key":"461_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102887","volume":"236","author":"WL Neuhuber","year":"2021","unstructured":"Neuhuber WL, Berthoud H-R. Functional anatomy of the vagus system\u2013emphasis on the somato-visceral interface. Auton Neurosci. 2021;236: 102887.","journal-title":"Auton Neurosci"},{"issue":"17","key":"461_CR127","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106320","volume":"40","author":"C Chen","year":"2021","unstructured":"Chen C, Zhou Y, Wang H, Alam A, Kang SS, Ahn EH, et al. Gut inflammation triggers C\/EBP\u03b2\/\u03b4-secretase-dependent gut-to-brain propagation of A\u03b2 and Tau fibrils in Alzheimer\u2019s disease. EMBO J. 2021;40(17): e106320.","journal-title":"Embo j"},{"issue":"1","key":"461_CR128","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13(1):21.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"461_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mds.29620","volume":"39","author":"Y Yang","year":"2024","unstructured":"Yang Y, Stewart T, Zhang C, Wang P, Xu Z, Jin J, et al. Erythrocytic alpha-synuclein and the gut microbiome: kindling of the gut-brain axis in Parkinson\u2019s disease. Mov Disord. 2024;39(1):40\u201352.","journal-title":"Mov Disord"},{"issue":"1","key":"461_CR130","doi-asserted-by":"publisher","first-page":"2167172","DOI":"10.1080\/19490976.2023.2167172","volume":"15","author":"J Jin","year":"2023","unstructured":"Jin J, Xu Z, Zhang L, Zhang C, Zhao X, Mao Y, et al. Gut-derived \u03b2-amyloid: likely a centerpiece of the gut-brain axis contributing to Alzheimer\u2019s pathogenesis. Gut Microbes. 2023;15(1):2167172.","journal-title":"Gut Microbes"},{"issue":"21","key":"461_CR131","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","volume":"112","author":"J Xiang","year":"2024","unstructured":"Xiang J, Tang J, Kang F, Ye J, Cui Y, Zhang Z, et al. Gut-induced alpha-synuclein and Tau propagation initiate Parkinson\u2019s and Alzheimer\u2019s disease co-pathology and behavior impairments. Neuron. 2024;112(21):3585.","journal-title":"Neuron"},{"issue":"5","key":"461_CR132","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awaa096","volume":"143","author":"ML Arotcarena","year":"2020","unstructured":"Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain. 2020;143(5):1462\u201375.","journal-title":"Brain"},{"issue":"1","key":"461_CR133","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction\u2014the disregarded partner of Alzheimer\u2019s disease. Alzheimers Dement. 2019;15(1):158\u201367.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"9","key":"461_CR134","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T. Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. 2017;18(9):1965.","journal-title":"Int J Mol Sci"},{"key":"461_CR135","doi-asserted-by":"crossref","unstructured":"Akhter F, Akhter A, Kesari KK, Javed R, Ruokolainen J, Vuorinen T. RAGE exacerbate amyloid beta (A\u03b2) induced alzheimer pathology: A systemic overview. . In: Kesari, K. (eds) Networking of Mutagens in Environmental Toxicology. Environmental Science and Engineering. Springer, Cham; 2019: 159\u2013170. https:\/\/doi.org\/10.1007\/978-3-319-96511-6_9","DOI":"10.1007\/978-3-319-96511-6_9"},{"issue":"1","key":"461_CR136","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12951-023-02081-0","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu Q, Li D, Pan X, Liang Y. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification. J Nanobiotechnology. 2023;21(1):334.","journal-title":"J Nanobiotechnology"},{"issue":"10","key":"461_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011743","volume":"19","author":"JY Ha","year":"2023","unstructured":"Ha JY, Seok J, Kim SJ, Jung HJ, Ryu KY, Nakamura M, et al. Periodontitis promotes bacterial extracellular vesicle-induced neuroinflammation in the brain and trigeminal ganglion. PLoS Pathog. 2023;19(10): e1011743.","journal-title":"PLoS Pathog"},{"issue":"2","key":"461_CR138","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000527182","volume":"113","author":"EA Makrygianni","year":"2023","unstructured":"Makrygianni EA, Chrousos GP. Extracellular vesicles and the stress system. Neuroendocrinology. 2023;113(2):120\u201367.","journal-title":"Neuroendocrinology"},{"issue":"1","key":"461_CR139","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","volume":"5","author":"J Matsumoto","year":"2017","unstructured":"Matsumoto J, Stewart T, Sheng L, Li N, Bullock K, Song N, et al. Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson\u2019s disease? Acta Neuropathol Commun. 2017;5(1):71.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"461_CR140","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40478-020-00983-w","volume":"8","author":"L Sheng","year":"2020","unstructured":"Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P, et al. Erythrocytic \u03b1-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson\u2019s disease pathogenesis. Acta Neuropathol Commun. 2020;8(1):102.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"461_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16095","volume":"31","author":"M Bruno","year":"2024","unstructured":"Bruno M, Bonomi CG, Ricci F, Di Donna MG, Mercuri NB, Koch G, et al. Blood\u2013brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer\u2019s disease. Eur J Neurol. 2024;31(1): e16095.","journal-title":"Eur J Neurol"},{"issue":"39","key":"461_CR142","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406479121","volume":"121","author":"Y Kim","year":"2024","unstructured":"Kim Y, McInnes J, Kim J, Liang YHW, Veeraragavan S, Garza AR, et al. Olfactory deficit and gastrointestinal dysfunction precede motor abnormalities in alpha-Synuclein G51D knock-in mice. Proc Natl Acad Sci U S A. 2024;121(39): e2406479121.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"461_CR143","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1172\/JCI127330","volume":"129","author":"RE Musgrove","year":"2019","unstructured":"Musgrove RE, Helwig M, Bae E-J, Aboutalebi H, Lee S-J, Ulusoy A, et al. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular \u03b1-synuclein transfer. J Clin Investig. 2019;129(9):3738\u201353.","journal-title":"J Clin Investig"},{"issue":"4","key":"461_CR144","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon S-H, Kam T-I, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627\u201341.","journal-title":"Neuron"},{"issue":"4","key":"461_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12374","volume":"24","author":"Q Lei","year":"2021","unstructured":"Lei Q, Wu T, Wu J, Hu X, Guan Y, Wang Y, et al. Roles of \u03b1-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson\u2019s disease progression. Mol Med Rep. 2021;24(4):1\u201314.","journal-title":"Mol Med Rep"},{"issue":"2","key":"461_CR146","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L. \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(2): a009399.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"461_CR147","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/glia.24109","volume":"70","author":"G Lan","year":"2022","unstructured":"Lan G, Wang P, Chan RB, Liu Z, Yu Z, Liu X, et al. Astrocytic VEGFA: an essential mediator in blood-brain-barrier disruption in Parkinson\u2019s disease. Glia. 2022;70(2):337\u201353.","journal-title":"Glia"},{"issue":"6","key":"461_CR148","doi-asserted-by":"publisher","first-page":"13261","DOI":"10.1111\/bpa.13261","volume":"34","author":"QJ Zhang","year":"2024","unstructured":"Zhang QJ, Lin J, Wang YL, Chen L, Ding Y, Zheng FZ, et al. Detection of pTDP-43 via routine muscle biopsy: a promising diagnostic biomarker for amyotrophic lateral sclerosis. Brain Pathol. 2024;34(6):13261.","journal-title":"Brain Pathol"},{"issue":"10","key":"461_CR149","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci. 2018;21(10):1332\u201340.","journal-title":"Nat Neurosci"},{"issue":"1","key":"461_CR150","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-immunol-101921-035222","volume":"42","author":"A Mary","year":"2024","unstructured":"Mary A, Mancuso R, Heneka MT. Immune activation in Alzheimer disease. Annu Rev Immunol. 2024;42(1):585\u2013613.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"461_CR151","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41467-024-45627-y","volume":"15","author":"K Juul-Madsen","year":"2024","unstructured":"Juul-Madsen K, Parbo P, Ismail R, Ovesen PL, Schmidt V, Madsen LS, et al. Amyloid-beta aggregates activate peripheral monocytes in mild cognitive impairment. Nat Commun. 2024;15(1):1224.","journal-title":"Nat Commun"},{"issue":"2","key":"461_CR152","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3233\/JAD-240096","volume":"99","author":"B Wu","year":"2024","unstructured":"Wu B, Chen M, Meng L, Tian Q, Dong Z. Osteoclasts link dysregulated peripheral degradation processes and accelerated progression in Alzheimer\u2019s disease. J Alzheimers Dis. 2024;99(2):773\u201385.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"461_CR153","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-023-03003-5","volume":"21","author":"M Shi","year":"2024","unstructured":"Shi M, Chu F, Zhu F, Zhu J. Peripheral blood amyloid-beta involved in the pathogenesis of Alzheimer\u2019s disease via impacting on peripheral innate immune cells. J Neuroinflammation. 2024;21(1):5.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"461_CR154","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13073-023-01205-3","volume":"15","author":"DW Sirkis","year":"2023","unstructured":"Sirkis DW, Warly Solsberg C, Johnson TP, Bonham LW, Sturm VE, Lee SE, et al. Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy. Genome Med. 2023;15(1):53.","journal-title":"Genome Med"},{"issue":"1","key":"461_CR155","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13195-022-00968-y","volume":"14","author":"JH Hou","year":"2022","unstructured":"Hou JH, Ou YN, Xu W, Zhang PF, Tan L, Yu JT, et al. Association of peripheral immunity with cognition, neuroimaging, and Alzheimer\u2019s pathology. Alzheimers Res Ther. 2022;14(1):29.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"461_CR156","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-022-02413-1","volume":"19","author":"Z Liu","year":"2022","unstructured":"Liu Z, Chan RB, Cai Z, Liu X, Wu Y, Yu Z, et al. Alpha-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson\u2019s disease. J Neuroinflammation. 2022;19(1):53.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"461_CR157","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12974-022-02421-1","volume":"19","author":"H Quek","year":"2022","unstructured":"Quek H, Cuni-Lopez C, Stewart R, Colletti T, Notaro A, Nguyen TH, et al. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. J Neuroinflammation. 2022;19(1):58.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"461_CR158","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2016.89","volume":"95","author":"L Zondler","year":"2017","unstructured":"Zondler L, Feiler MS, Freischmidt A, Ruf WP, Ludolph AC, Danzer KM, et al. Impaired activation of ALS monocytes by exosomes. Immunol Cell Biol. 2017;95(2):207\u201314.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"461_CR159","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimers Res Ther. 2021;13(1):80.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"461_CR160","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"461_CR161","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic alzheimer disease: the trailblazer-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"12","key":"461_CR162","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","volume":"79","author":"MJ Pontecorvo","year":"2022","unstructured":"Pontecorvo MJ, Lu M, Burnham SC, Schade AE, Dage JL, Shcherbinin S, et al. Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic alzheimer disease: a secondary analysis of the trailblazer-ALZ randomized clinical trial. JAMA Neurol. 2022;79(12):1250\u20139.","journal-title":"JAMA Neurol"},{"issue":"1","key":"461_CR163","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3233\/ADR-230025","volume":"7","author":"DA Loeffler","year":"2023","unstructured":"Loeffler DA. Antibody-mediated clearance of brain amyloid-\u03b2: mechanisms of action, effects of natural and monoclonal anti-A\u03b2 antibodies, and downstream effects. J Alzheimers Dis Rep. 2023;7(1):873\u201399.","journal-title":"J Alzheimers Dis Rep"},{"issue":"12","key":"461_CR164","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of alzheimer\u2019s amyloid-ss(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106(12):1489\u201399.","journal-title":"J Clin Invest"},{"issue":"3","key":"461_CR165","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, et al. LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43(3):333\u201344.","journal-title":"Neuron"},{"issue":"10","key":"461_CR166","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1038\/s41380-020-0842-1","volume":"26","author":"HL Sun","year":"2021","unstructured":"Sun HL, Chen SH, Yu ZY, Cheng Y, Tian DY, Fan DY, et al. Blood cell-produced amyloid-\u03b2 induces cerebral Alzheimer-type pathologies and behavioral deficits. Mol Psychiatry. 2021;26(10):5568\u201377.","journal-title":"Mol Psychiatry"},{"issue":"22","key":"461_CR167","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/sciadv.adl1123","volume":"10","author":"PY Sun","year":"2024","unstructured":"Sun PY, Liu J, Hu JN, Tu YF, Jiang Q, Jia YJ, et al. Rejuvenation of peripheral immune cells attenuates Alzheimer\u2019s disease-like pathologies and behavioral deficits in a mouse model. Sci Adv. 2024;10(22):1123.","journal-title":"Sci Adv"},{"issue":"6","key":"461_CR168","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-023-02559-z","volume":"145","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, He CY, Tian DY, Chen SH, Ren JR, Sun HL, et al. Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol. 2023;145(6):717\u201331.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"461_CR169","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","volume":"26","author":"DY Tian","year":"2021","unstructured":"Tian DY, Cheng Y, Zhuang ZQ, He CY, Pan QG, Tang MZ, et al. Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):6074\u201382.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"461_CR170","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13533","volume":"21","author":"ZY Yu","year":"2022","unstructured":"Yu ZY, Chen DW, Tan CR, Zeng GH, He CY, Wang J, et al. Physiological clearance of A\u03b2 by spleen and splenectomy aggravates Alzheimer-type pathogenesis. Aging Cell. 2022;21(1): e13533.","journal-title":"Aging Cell"},{"key":"461_CR171","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.2147\/NDT.S186118","volume":"14","author":"N Kitaguchi","year":"2018","unstructured":"Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, et al. Removal of blood amyloid-\u03b2 with hemodialysis reduced brain amyloid-\u03b2, confirmed by brain imaging: a case report. Neuropsychiatr Dis Treat. 2018;14:2931\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"461_CR172","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-017-1721-y","volume":"134","author":"WS Jin","year":"2017","unstructured":"Jin WS, Shen LL, Bu XL, Zhang WW, Chen SH, Huang ZL, et al. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP\/PS1 mouse model. Acta Neuropathol. 2017;134(2):207\u201320.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"461_CR173","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41380-022-01679-4","volume":"27","author":"A Urayama","year":"2022","unstructured":"Urayama A, Moreno-Gonzalez I, Morales-Scheihing D, Kharat V, Pritzkow S, Soto C. Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer\u2019s disease by whole blood exchange. Mol Psychiatry. 2022;27(10):4285\u201396.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"461_CR174","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.3233\/JAD-220742","volume":"90","author":"C Zhu","year":"2022","unstructured":"Zhu C, Zhu J, Xiang Y, Bu XL, JinWang WSYJ. A conceptual study on the peripheral clearance of brain-derived \u03b1-synuclein in humans. J Alzheimers Dis. 2022;90(4):1485\u201392.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"461_CR175","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molmed.2015.04.005","volume":"21","author":"A Mukherjee","year":"2015","unstructured":"Mukherjee A, Morales-Scheihing D, Butler PC, Soto C. Type 2 diabetes as a protein misfolding disease. Trends Mol Med. 2015;21(7):439\u201349.","journal-title":"Trends Mol Med"},{"key":"461_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2023.102462","volume":"226","author":"L Meng","year":"2023","unstructured":"Meng L, Li Y, Liu C, Zhang G, Chen J, Xiong M, et al. Islet amyloid polypeptide triggers alpha-synuclein pathology in Parkinson\u2019s disease. Prog Neurobiol. 2023;226: 102462.","journal-title":"Prog Neurobiol"},{"issue":"10","key":"461_CR177","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.4103\/1673-5374.369095","volume":"18","author":"AS Bortoletto","year":"2023","unstructured":"Bortoletto AS, Parchem RJ. A pancreatic player in dementia: pathological role for islet amyloid polypeptide accumulation in the brain. Neural Regen Res. 2023;18(10):2141\u20136.","journal-title":"Neural Regen Res"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-024-00461-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-024-00461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:47:11Z","timestamp":1736995631000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-024-00461-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1186\/s40035-024-00461-6","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}